Today’s Research Reports on Trending Tickers: Heron Therapeutics and Array BioPharma

NEW YORK, NY / ACCESSWIRE / June 28, 2018 / U.S. equities fell sharply on Wednesday, weighed by losses from the consumer staples and technology sectors. The Dow Jones Industrial Average decreased 0.68 percent to close at 24,117.59, while the S&P 500 Index fell 0.86 percent to close at 2,699.63. The Nasdaq Composite Index declined 1.54 percent to close at 7,455.09.

“To a certain degree, investors are looking for something to be worried about. Stocks aren’t far from all-time highs, and for a lot of people that’s hard to justify,” said Dan Wantrobski, director of research at Janney Montgomery Scott. “However, I think volatility is returning to the U.S. market and that we could see another correction cycle. I’m not calling for a structural downturn, but tariffs and trade wars could exacerbate the weakness,” Wantrobski added.

RDI Initiates Coverage on:

Heron Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=HRTX

Array BioPharma Inc.
https://rdinvesting.com/news/?ticker=ARRY

Heron Therapeutics’s stock jumped 3.58% Wednesday, to close the day at $42.00. The stock recorded a trading volume of 1,829,037 shares, which was above its three months average volume of 1,411,401 shares. In the last year, Heron Therapeutics’s shares have traded in a range of 12.70 – 42.90. The share price has gained 230.71% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $32.49 is above its 200-day moving average of $26.03. Shares of Heron Therapeutics have gained roughly 33.55 percent in the past month and are up 132.04 percent year-to-date.

Access RDI’s Heron Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=HRTX

On Wednesday, shares of Array BioPharma recorded a trading volume of 5,161,208 shares, which was above the three months average volume of 2,644,035 shares. The stock ended the day 4.86% lower at $17.60. The share price has fallen 12.91% from its 52-week high with a 52-week trading range of 7.15 – 20.21. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $16.82 is above its 200-day moving average of $15.49. Shares of Array BioPharma have gained roughly 10.76 percent in the past month and are up 37.5 percent year-to-date.

Access RDI’s Array BioPharma Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ARRY

Our Actionable Research on Heron Therapeutics, Inc. (NASDAQ :HRTX) and Array BioPharma Inc. (NYSE :ARRY) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 504004